Hormone refractory prostate cancer (HRPC) is the progression of disease in the presence of castrate serum levels of testosterone with a median survival of approximately 1 year.

• 激素难治性前列腺癌（HRPC）是在中位存活时间约为1年的时间里出现睾酮的去势血清水平的疾病的进展。